Thomas M. Rinderknecht is a Swiss businessperson who has been the head of 15 different companies. Presently, Dr. Rinderknecht is Chairman at Spanset Inter AG, Chairman at Caveat Holding AG, Chairman for Twin Dolphins Holding AG, Chairman of Miralco Holding AG, Chairman at Munich Partners Invest AG, Chairman at Munich Partners AG, Chairman at First 4G AG, Chairman at First ELF AG, Chairman for PlusFour AG, Chairman of APR Applied Pharma Research SA, Chairman at Canyon Pharmaceuticals AG and Chairman of First Salt AG.
He is also Member of Zurich Bar Association and Senior Partner at Badertscher Rechtsanwälte AG and on the board of 10 other companies.
Dr. Rinderknecht previously held the position of Chairman at Vecap Venture Capital Partners AG, Chairman at FLHBrands AG, Senior Partner at Rinderknecht Klein & Stadelhofer and Chairman of Ganymed Pharmaceuticals AG.
Dr. Rinderknecht received a doctorate and a graduate degree from the University of Zurich.